A

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

The Lancet Oncology

Authors 0

  1. Author list not loaded yet.

Cited by 11 stored of 1,483

11 results

References 0